HERSHEY CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HERSHEY CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $2.19B | Feb 17, 2021 |
| FY2020 | Sep 27, 2020 | $2.22B | Feb 17, 2021 |
| FY2020 | Jun 28, 2020 | $1.71B | Feb 17, 2021 |
| FY2020 | Mar 29, 2020 | $2.04B | Feb 17, 2021 |
| FY2019 | Dec 31, 2019 | $2.07B | Feb 20, 2020 |
| FY2019 | Sep 29, 2019 | $2.13B | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $1.77B | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $2.02B | Feb 20, 2020 |
| FY2018 | Dec 31, 2018 | $1.99B | Feb 22, 2019 |
| FY2018 | Sep 30, 2018 | $2.08B | Feb 22, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.69B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $11.20B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $11.16B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $10.42B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $8.97B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $8.15B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $7.99B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $7.79B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $7.52B | Feb 20, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.94B | Feb 27, 2018 |
| FY2017 | Oct 1, 2017 | $2.03B | Feb 27, 2018 |
| FY2017 | Jul 2, 2017 | $1.66B | Feb 27, 2018 |
| FY2017 | Apr 2, 2017 | $1.88B | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $1.97B | Feb 27, 2018 |
| FY2017 | Oct 2, 2016 | $2.00B | Feb 27, 2018 |
| FY2017 | Jul 3, 2016 | $1.64B | Feb 27, 2018 |
| FY2017 | Apr 3, 2016 | $1.83B | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | $1.91B | Feb 21, 2017 |
| FY2016 | Oct 4, 2015 | $1.96B | Feb 21, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.92B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $5.30B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $5.00B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $4.50B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $4.05B | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $962.07M | Feb 17, 2021 |
| FY2020 | Sep 27, 2020 | $1.08B | Feb 17, 2021 |
| FY2020 | Jun 28, 2020 | $792.55M | Feb 17, 2021 |
| FY2020 | Mar 29, 2020 | $866.62M | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | $911.91M | Feb 17, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $883.26M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.22B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $1.86B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $1.64B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.48B | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $291.39M | Feb 17, 2021 |
| FY2020 | Sep 27, 2020 | $447.28M | Feb 17, 2021 |
| FY2020 | Jun 28, 2020 | $268.90M | Feb 17, 2021 |
| FY2020 | Mar 29, 2020 | $271.14M | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | $207.19M | Feb 17, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.44B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.90B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.56B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $2.26B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $2.04B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.78B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.60B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.62B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $1.31B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.26B | Feb 22, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.66M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $55.80M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $50.03M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $46.94M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $40.11M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $37.58M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $37.15M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $38.52M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $45.85M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $47.27M | Feb 22, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.46B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.37B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.44B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $2.24B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $2.00B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.89B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.91B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.87B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $1.89B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.89B | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.28B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.53B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.32B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $2.33B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $2.08B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.70B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.76B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.60B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $1.25B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.01B | Feb 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $454.62M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $605.94M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $771.11M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $519.48M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $495.88M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $441.63M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $318.19M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $328.60M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $257.68M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $269.48M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.74B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $12.95B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $11.90B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $10.95B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $10.41B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.13B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $8.14B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $7.70B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $5.55B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $5.52B | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.10B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $8.23B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $7.80B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $7.65B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $7.66B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $6.89B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $6.40B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $6.30B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $4.62B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $4.70B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.64B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $4.71B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $4.10B | Feb 17, 2026 |
| FY2025 | Dec 31, 2022 | $3.30B | Feb 17, 2026 |
| FY2024 | Dec 31, 2021 | $2.76B | Feb 18, 2025 |
| FY2021 | Dec 31, 2020 | $2.23B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.74B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $1.40B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $915.34M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $785.86M | Feb 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.00B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.71B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.70B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $2.61B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $2.63B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.99B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.99B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.80B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $821.06M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $812.34M | Feb 22, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.50B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $5.70B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $4.56B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $3.59B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.72B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.93B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.29B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $7.03B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $6.37B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $6.12B | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $588.00M | Feb 22, 2019 |
| FY2018 | Dec 31, 2017 | $380.18M | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $296.97M | Feb 22, 2019 |
| FY2018 | Dec 31, 2015 | $346.53M | Feb 22, 2019 |
| FY2017 | Dec 31, 2014 | $374.85M | Feb 27, 2018 |
| FY2016 | Dec 31, 2013 | $1.12B | Feb 21, 2017 |
| FY2015 | Dec 31, 2012 | $728.27M | Feb 26, 2016 |
| FY2014 | Dec 31, 2011 | $693.69M | Feb 20, 2015 |
| FY2013 | Dec 31, 2010 | $884.64M | Feb 21, 2014 |
| FY2012 | Dec 31, 2009 | $253.61M | Feb 22, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $4.53B | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | $4.23B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $3.26B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $2.36B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.35B | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | $2.06B | Feb 21, 2017 |
| FY2015 | Dec 31, 2014 | $1.79B | Feb 26, 2016 |
| FY2014 | Dec 31, 2013 | $1.80B | Feb 20, 2015 |
| FY2013 | Dec 31, 2012 | $1.79B | Feb 21, 2014 |
| FY2012 | Dec 31, 2011 | $1.85B | Feb 22, 2013 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 202.84M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 202.38M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 204.39M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 204.96M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 206.11M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 208.23M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | 208.83M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | 209.73M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | 210.86M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | 212.26M | Feb 22, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $1.08B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $889.07M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $775.03M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $685.99M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $640.73M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $610.31M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $562.52M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $526.27M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $499.48M | Feb 22, 2019 |